Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029736 | SCV000052389 | uncertain | Marfan syndrome | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Uncertain significance. |
Laboratory for Molecular Medicine, |
RCV000035201 | SCV000058843 | likely benign | not specified | 2018-12-31 | criteria provided, single submitter | clinical testing | The p.Ser1481Gly variant in FBN1 is classified as likely benign because it has b een identified in 0.4% (97/24962) of African chromosomes by gnomAD (http://gnoma d.broadinstitute.org). ACMG/AMP Criteria applied: BS1. |
Eurofins Ntd Llc |
RCV000724063 | SCV000229808 | uncertain significance | not provided | 2014-09-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000515317 | SCV000611391 | uncertain significance | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2017-05-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001176800 | SCV000738752 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-11-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001088381 | SCV000753160 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000029736 | SCV000781370 | likely benign | Marfan syndrome | 2016-11-01 | criteria provided, single submitter | clinical testing | |
SIB Swiss Institute of Bioinformatics | RCV000029736 | SCV000803588 | likely benign | Marfan syndrome | 2018-05-31 | criteria provided, single submitter | curation | This variant is interpreted as a Likely Benign, for Marfan syndrome, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: BP2 => Observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder or observed in cis with a pathogenic variant in any inheritance pattern (PMID:21542060). BS2 => Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age. |
ARUP Laboratories, |
RCV000035201 | SCV000883854 | likely benign | not specified | 2018-10-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724063 | SCV000977387 | likely benign | not provided | 2020-12-07 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24793577, 21542060, 27647783) |
Color Diagnostics, |
RCV001176800 | SCV001340855 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-14 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV000029736 | SCV001469041 | likely benign | Marfan syndrome | 2020-12-07 | criteria provided, single submitter | clinical testing | |
Centre of Medical Genetics, |
RCV000029736 | SCV002025458 | uncertain significance | Marfan syndrome | 2021-03-01 | criteria provided, single submitter | research | PP4 |
CHEO Genetics Diagnostic Laboratory, |
RCV001176800 | SCV002041985 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-10-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541020 | SCV004761636 | likely benign | FBN1-related disorder | 2021-04-14 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |